Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical Trial of APD811 …
Arena Pharmaceuticals Initiates Phase 1 Multiple Dose Clinical Trial of APD811 …
Filed under: drug treatment news 2012
SAN DIEGO, Oct. 12, 2012 — /PRNewswire/ — Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today the initiation of dosing in a Phase 1 multiple dose clinical trial of APD811, a novel oral drug candidate discovered by Arena that targets the …
Read more on The Herald | HeraldOnline.com
Bogotá: 15.4% of homicides are related to drug use
Filed under: drug treatment news 2012
Mobile units from the Treatment Centers for Drug Addicts (CAMAD) dispense controlled amounts of narcotics to addicts. One of its objectives is to reduce the number of drug-related homicides in the nation's capital. (Courtesy of the Office of the Mayor …
Read more on Infosurhoy
Alzheimer's Patients Show Significant Slowing of Decline with New Drug
Filed under: drug treatment news 2012
Oct. 9, 2012 – The quest for a drug to treat Alzheimer's disease continues its bumpy progress as Eli Lilly and Company announced yesterday that an experimental drug therapy called solanezumab targeting mild to moderate Alzheimer's disease, that did not …
Read more on SeniorJournal.com
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic …
Filed under: drug treatment news 2012
Which TKI Should Be Recommended as Initial Treatment for CML in Chronic Phase? By Charles A. Schiffer, MD1 | October 12, 2012. 1Karmanos Cancer Institute, … Approximately 60% of newly diagnosed CML patients will remain in complete cytogenetic …
Read more on Cancer Network